APA (7th ed.) Citation

J, B., R, A., M, K., A, M., HM, H., L, W., . . . B, G. (2025). A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: A double-blind, randomized, phase 1 study in Switzerland. BMC infectious diseases, 25(1), 472. https://doi.org/10.1186/s12879-025-10844-3

Chicago Style (17th ed.) Citation

J, Besson, et al. "A Gold Nanoparticle/peptide Vaccine Designed to Induce SARS-CoV-2-specific CD8 T Cells: A Double-blind, Randomized, Phase 1 Study in Switzerland." BMC Infectious Diseases 25, no. 1 (2025): 472. https://doi.org/10.1186/s12879-025-10844-3.

MLA (9th ed.) Citation

J, Besson, et al. "A Gold Nanoparticle/peptide Vaccine Designed to Induce SARS-CoV-2-specific CD8 T Cells: A Double-blind, Randomized, Phase 1 Study in Switzerland." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 472, https://doi.org/10.1186/s12879-025-10844-3.